NHANES 2001 – 2002: Herpes Simplex Virus Type-2

NHANES 2001 - 2002: Herpes Simplex Virus Type-2

These antibodies produced by plasma cells are armed with 10 extensions to catch and kill the invading agents compared to two arms for igg antibodies. Type I usually infects the non-genital mucosal surfaces. Recurrences of encephalitis are rare and limited to a few cases in the literature. HSV-2 is a sexually transmitted infection and can be used as a marker for sexual transmission of other infectious agents. Short stays, such as holidays, are not taken into account. HSV-2 infection is one of the best markers of sexual risk factors leading to sexually transmitted infections, because: (a) HSV-2 infections are common and, thus, HSV-2 rates are a measure of sexual risk in the broader population beyond high risk groups; (b) HSV-2 infection is almost always a result of sexual transmission and, thus, a specific measure of sexually transmitted infection; (c) HSV-2 infections are not curable and, thus, HSV-2 risk is not influenced by health care-seeking factors; and (d) sensitive, specific, and relatively inexpensive tests for HSV-2 antibody are available. HSV-2 is a very important marker for monitoring the impact of large national efforts, motivated by the HIV epidemic, to reduce risky sexual behaviors.

The NHANES laboratory data can be linked to NHANES sexual behavior questions to assist in the understanding of national trends in HIV and sexually transmitted diseases. Encephalitis was diagnosed based on a positive polymerase chain reaction for HSV in the cerebrospinal fluid. Participants 14–49 years of age who did not meet any of the exclusion criteria were tested for HSV-1 and HSV-2. The ESR will be employed/enrolled locally in either Denmark, Germany, the Netherlands, United Kingdom, or Italy. Please see Analytic Notes about availability of HSV-2 data for persons 14–17 years of age. Blood specimens collected through venipuncture were processed, stored, and shipped to Emory University for testing. Detailed specimen collection and processing instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM).
NHANES 2001 - 2002: Herpes Simplex Virus Type-2

Although extensive antigenic cross-reactivity exists between the two viral types of herpes, a viral glycoprotein specific for herpes simplex virus type 2 (HSV-2) (designated gG-2) and a glycoprotein specific for herpes simplex virus type 1 (HSV-1) (designated gG-1) have been identified. Monoclonal antibodies and affinity chromatography have been used to purify these glycoproteins and thus provide antigens for type-specific herpes serologic assays. Solid-phase enzymatic immunodot assays are used to detect antibodies reactive to these antigens. The purified glycoprotein, gG-1 or gG-2, is adsorbed to the center of a nitrocellulose disk. The rest of the disk surface is coated with bovine serum albumin to prevent further nonspecific protein adsorption. Incubation of test serum with the disk allows specific antibodies, if present, to bind to the immobilized antigen. After extensive washing to remove non-reactive antibodies, the bound antibodies are detected by sequential treatment with peroxidase-conjugated goat-anti-human IgG and the enzyme substrate (H2O2 with chromogen 4-chloro-1-naphthol).

A positive reaction is demonstrated by the appearance of a blue dot at the center of the disk. Serum reactive to an immunodot charged with gG-1 indicates the person being tested has HSV-1 infection. Serum reactive to an immunodot charged with gG-2 indicates the person being tested has HSV-2 infection. The NHANES quality control and quality assurance (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES Laboratory/Medical Technologists Procedures Manual (LPM). Read the General Documentation of Laboratory Data file for detailed QA/QC protocols. The type-specific immunodot assays used to detect antibodies reactive to HSV-1 & HSV-2 antigens in NHANES 2007–2008 are the same assays as those used in NHANES 1999–2006 and NHANES III.

Therefore, HSV-1 and HSV-2 results from these surveys are identical and comparable for trend analyses. The public release data file includes HSV-1 data for participants aged 14–49 and HSV-2 data for participants aged 18–49. HSV-2 data for youth aged 14–17 years are available through the NCHS Research Data Center (RDC). Exam sample weights should be used for analyses. Please refer to the Analytic Guidelines for further details on the use of sample weights and other analytic issues. The Analytic Guidelines are available on the NHANES website.

You may also like